canadian pharmacy glp-1 Health Canada approves first pill for high-risk type 2 diabetes patients Health Canada approves 1st GLP-1

Insurance coverage for GLP-1 medications in prediabetes remains limited, with most plans requiring a type 2 diabetes diagnosis first

Learn screening rules, timing, side effects, and what to ask your clinic before you apply.

In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)

Science-backed guidance from the authority.

Ongoing check-ins and nurse access keep you on track